[go: up one dir, main page]

ATE84217T1 - Fragmente und fraktionen von heparin mit wirkung gegen hiv. - Google Patents

Fragmente und fraktionen von heparin mit wirkung gegen hiv.

Info

Publication number
ATE84217T1
ATE84217T1 AT89202061T AT89202061T ATE84217T1 AT E84217 T1 ATE84217 T1 AT E84217T1 AT 89202061 T AT89202061 T AT 89202061T AT 89202061 T AT89202061 T AT 89202061T AT E84217 T1 ATE84217 T1 AT E84217T1
Authority
AT
Austria
Prior art keywords
hiv
fractions
fragments
active anti
heparin
Prior art date
Application number
AT89202061T
Other languages
English (en)
Inventor
Henricus Carl J Ottenheijm
Franciscus C Den Hollander
Erik Desire A De Clercq
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Application granted granted Critical
Publication of ATE84217T1 publication Critical patent/ATE84217T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078Degradation products

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT89202061T 1988-08-24 1989-08-09 Fragmente und fraktionen von heparin mit wirkung gegen hiv. ATE84217T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8802087 1988-08-24
EP89202061A EP0355905B1 (de) 1988-08-24 1989-08-09 Fragmente und Fraktionen von Heparin mit Wirkung gegen HIV

Publications (1)

Publication Number Publication Date
ATE84217T1 true ATE84217T1 (de) 1993-01-15

Family

ID=19852794

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89202061T ATE84217T1 (de) 1988-08-24 1989-08-09 Fragmente und fraktionen von heparin mit wirkung gegen hiv.

Country Status (13)

Country Link
EP (1) EP0355905B1 (de)
JP (1) JPH02108624A (de)
KR (1) KR0143084B1 (de)
AT (1) ATE84217T1 (de)
AU (1) AU617850B2 (de)
CA (1) CA1330305C (de)
DE (1) DE68904264T2 (de)
DK (1) DK416089A (de)
ES (1) ES2053953T3 (de)
IE (1) IE61565B1 (de)
NZ (1) NZ230394A (de)
PT (1) PT91524B (de)
ZA (1) ZA896231B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08109134A (ja) * 1994-10-11 1996-04-30 Sanwa Kagaku Kenkyusho Co Ltd 細胞変成抑制並びに臓器毒性軽減剤
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
GB2299998B (en) * 1995-03-31 1997-03-26 Hamilton Civic Hospitals Res Compositions for inhibiting thrombogenesis
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
EP1331932B1 (de) * 2000-11-09 2007-04-04 Contrimmune Biotechnology Inc. Verwendung von xestospongin c zur behandlung oder vorbeugung einer hiv-infektion
FR2838649B1 (fr) * 2002-04-19 2006-01-13 Commissariat Energie Atomique Composition anti-vih, procede de fabrication et medicament
US20040229778A1 (en) * 2003-05-13 2004-11-18 Elmaleh David R. Pharmaceutical compositions of antithrombin III for the treatment of retroviral diseases
EP1597978A1 (de) 2004-05-17 2005-11-23 Nutricia N.V. Synergie von GOS und polyfruktose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
EP1721611A1 (de) * 2005-04-21 2006-11-15 N.V. Nutricia Nahrungsergänzungspräparat mit Oligosacchariden für eine Kategorie von HIV Patienten
DE112010002825B4 (de) 2009-07-03 2017-09-14 Honda Motor Co., Ltd. Fahrzeugsitz
RU2013113723A (ru) 2010-09-14 2014-10-20 Ф.Хоффманн-Ля Рош Аг Гибридный полипептид с серпиновым "пальцем"

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3422518A1 (de) * 1984-06-16 1985-12-19 B. Braun Melsungen Ag, 3508 Melsungen Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen
ZA878877B (en) * 1986-11-29 1988-05-24 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Treatment of diseases caused by viruses
AU4426289A (en) * 1988-10-05 1990-05-01 Nicola Diferrante Methods for interfering with hiv multiplication and composition for the treatment of aids

Also Published As

Publication number Publication date
IE61565B1 (en) 1994-11-16
ES2053953T3 (es) 1994-08-01
EP0355905B1 (de) 1993-01-07
DK416089D0 (da) 1989-08-23
PT91524A (pt) 1990-03-08
DE68904264T2 (de) 1993-05-27
IE892565L (en) 1990-02-24
JPH02108624A (ja) 1990-04-20
CA1330305C (en) 1994-06-21
KR900002788A (ko) 1990-03-23
DE68904264D1 (de) 1993-02-18
NZ230394A (en) 1997-02-24
EP0355905A1 (de) 1990-02-28
ZA896231B (en) 1990-05-30
PT91524B (pt) 1995-07-18
KR0143084B1 (ko) 1998-07-15
DK416089A (da) 1990-02-25
AU4001289A (en) 1990-03-01
AU617850B2 (en) 1991-12-05

Similar Documents

Publication Publication Date Title
ATE84217T1 (de) Fragmente und fraktionen von heparin mit wirkung gegen hiv.
ATE264914T1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
FI952302L (fi) Pyran-2-onit ja 5,6-dihydropyranonit, jotka ovat käyttökelpoisia HIV:n ja muiden retrovirusten hoidossa
FR2650598B1 (fr) Derives de l'albumine a fonction therapeutique
DE69233760D1 (de) Inhibitoren der menschlichen Elastase von Neutrophilen
ES2130114T3 (es) 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepinas y su uso en la prevencion o tratamiento de infeccion por hiv.
ATE100098T1 (de) Nukleoside, ihre herstellung und pharmazeutische zusammenstellungen.
DK538888D0 (da) Anvendelse af castanosperminestere til fremstilling af et farmaceutisk praeparat
ATE132163T1 (de) Neue polypeptide und damit hergestellte anti-hiv medikamente
DE69023708D1 (de) Anti-hiv-heilmittel.
DE69403063D1 (de) Gegen viren wirksame naphtochinon-verbindungen, zusammensetzungen und deren verwendungen
EP0311107A3 (de) Anti-HIV-aktive 3'-Fluoro-purin-2',3'-dideoxyriboside
ES2108680T3 (es) Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento.
DE68914990D1 (de) Verfahren zur inhibierung der wirkung des menschlichen immunschwäche-virus (hiv) in vivo.
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
ATE58478T1 (de) Zubereitungen und verfahren zum schutz von tlymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom.
KR950702838A (ko) 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4)
WO1990005523A3 (en) Phenanthrolinedicarboxylate esters, 4-aminoquinoline and isoquinoline derivatives as inhibitors of hiv reverse transcriptase
EP0311108A3 (de) Anti-HIV-aktive 3'-Azido-2,6-diaminopurine-2',3'-dideoxyriboside
BR0007627A (pt) Mutações de hiv-1 selecionadas por beta-2', 3' -didehidro-2', 3' -didesóxi-5-fluorocitidina
NO921513D0 (no) Komplekser av polyadenylsyre med polyuridylsyre
EP0305777A3 (de) Herstellung von Antigenen des Human Immunodeficiency Virus Typ 1 sowie deren Verwendung als diagnostisches Mittel und Therapeutikum
ATE185485T1 (de) Arzneimittel zur verhinderung einer infektion mit dem für aids verantwortlichen virus
DE68908757D1 (de) 5-Methoxypsoralen gegen Depressionen.
ATE64855T1 (de) Zubereitungen und verfahren zum schutz von tlymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee